PL343095A1 - Paroxetine compositions - Google Patents

Paroxetine compositions

Info

Publication number: PL343095A1
Authority: PL; Poland
Prior art keywords: paroxetine compositions; paroxetine; compositions
Prior art date: 1998-03-24

Application number

PL99343095A

Other languages

English (en)

Inventor

Andrew Simon Craig

Neal Ward

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-24

Filing date

1999-03-24

Publication date

2001-07-30

1999-03-24 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2001-07-30 Publication of PL343095A1 publication Critical patent/PL343095A1/xx

Links

AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title 1
AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title 1
239000000203 mixture Substances 0.000 title 1
229960002296 paroxetine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Psychology (AREA)
Inorganic Chemistry (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

PL99343095A 1998-03-24 1999-03-24 Paroxetine compositions PL343095A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9806312.6A GB9806312D0 (en)	1998-03-24	1998-03-24	Novel formulations
PCT/GB1999/000922 WO1999048499A1 (en)	1998-03-24	1999-03-24	Paroxetine compositions

Publications (1)

Publication Number	Publication Date
PL343095A1 true PL343095A1 (en)	2001-07-30

Family

ID=10829181

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL99343095A PL343095A1 (en)	1998-03-24	1999-03-24	Paroxetine compositions

Country Status (20)

Country	Link
EP (1)	EP1063993A1 (id)
JP (1)	JP2002507569A (id)
CN (1)	CN1125639C (id)
AP (1)	AP2000001914A0 (id)
AU (1)	AU754765B2 (id)
BG (1)	BG104865A (id)
BR (1)	BR9908991A (id)
CA (1)	CA2324612A1 (id)
EA (1)	EA003393B1 (id)
GB (1)	GB9806312D0 (id)
HU (1)	HUP0101326A3 (id)
ID (1)	ID26485A (id)
IL (1)	IL138478A0 (id)
NO (1)	NO313404B1 (id)
NZ (1)	NZ506893A (id)
PL (1)	PL343095A1 (id)
SK (1)	SK14102000A3 (id)
TR (1)	TR200002750T2 (id)
WO (1)	WO1999048499A1 (id)
ZA (1)	ZA200005697B (id)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9914600D0 (en) *	1999-06-22	1999-08-25	Smithkline Beecham Plc	Novel,process
DK200100341A (da) *	2001-03-02	2002-09-03	Gea Farmaceutisk Fabrik As	Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat
WO2005002541A2 (en) *	2003-07-02	2005-01-13	Abbott Laboratories	Process for preparing formulations of lipid-regulating drugs
US8062664B2 (en)	2003-11-12	2011-11-22	Abbott Laboratories	Process for preparing formulations of lipid-regulating drugs
HU1000278D0 (en) *	2010-05-28	2010-07-28	Egis Gyogyszergyar Nyilvanosan	Novel pharmaceutical use uf silicic acid
CN103961333B (zh) *	2014-05-07	2020-02-21	浙江华海药业股份有限公司	甲磺酸帕罗西汀胶囊及其制备方法
CN104027306A (zh) *	2014-06-25	2014-09-10	万特制药(海南)有限公司	帕罗西汀口服混悬液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1422263A (en) *	1973-01-30	1976-01-21	Ferrosan As	4-phenyl-piperidine compounds
EP0223403B1 (en) *	1985-10-25	1993-08-04	Beecham Group Plc	Piperidine derivative, its preparation, and its use as medicament
SK283608B6 (sk) *	1995-02-06	2003-10-07	Smithkline Beecham Plc	Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie
CA2206592A1 (en) *	1996-05-30	1997-11-30	Shu-Zhong Wang	Method of producing amorphous paroxetine hydrochloride

1998
- 1998-03-24 GB GBGB9806312.6A patent/GB9806312D0/en not_active Ceased
1999
- 1999-03-24 WO PCT/GB1999/000922 patent/WO1999048499A1/en not_active Ceased
- 1999-03-24 BR BR9908991-2A patent/BR9908991A/pt not_active IP Right Cessation
- 1999-03-24 JP JP2000537547A patent/JP2002507569A/ja active Pending
- 1999-03-24 EA EA200000977A patent/EA003393B1/ru not_active IP Right Cessation
- 1999-03-24 NZ NZ506893A patent/NZ506893A/xx unknown
- 1999-03-24 AP APAP/P/2000/001914A patent/AP2000001914A0/en unknown
- 1999-03-24 TR TR2000/02750T patent/TR200002750T2/xx unknown
- 1999-03-24 HU HU0101326A patent/HUP0101326A3/hu unknown
- 1999-03-24 AU AU30451/99A patent/AU754765B2/en not_active Withdrawn - After Issue
- 1999-03-24 CA CA002324612A patent/CA2324612A1/en not_active Abandoned
- 1999-03-24 IL IL13847899A patent/IL138478A0/xx unknown
- 1999-03-24 ID IDW20001883A patent/ID26485A/id unknown
- 1999-03-24 CN CN99804347A patent/CN1125639C/zh not_active Expired - Fee Related
- 1999-03-24 PL PL99343095A patent/PL343095A1/xx unknown
- 1999-03-24 SK SK1410-2000A patent/SK14102000A3/sk unknown
- 1999-03-24 EP EP99911940A patent/EP1063993A1/en not_active Withdrawn
2000
- 2000-09-22 NO NO20004740A patent/NO313404B1/no unknown
- 2000-10-16 ZA ZA200005697A patent/ZA200005697B/xx unknown
- 2000-10-16 BG BG104865A patent/BG104865A/xx unknown

Also Published As

Publication number	Publication date
NO313404B1 (no)	2002-09-30
NO20004740L (no)	2000-10-03
BR9908991A (pt)	2000-12-12
EA003393B1 (ru)	2003-04-24
WO1999048499A1 (en)	1999-09-30
TR200002750T2 (tr)	2000-12-21
CN1294512A (zh)	2001-05-09
HUP0101326A2 (hu)	2002-05-29
AU754765B2 (en)	2002-11-21
BG104865A (en)	2001-05-31
ZA200005697B (en)	2001-10-02
ID26485A (id)	2001-01-11
GB9806312D0 (en)	1998-05-20
CA2324612A1 (en)	1999-09-30
EP1063993A1 (en)	2001-01-03
HUP0101326A3 (en)	2002-06-28
AU3045199A (en)	1999-10-18
NZ506893A (en)	2003-06-30
IL138478A0 (en)	2001-10-31
EA200000977A1 (ru)	2001-02-26
AP2000001914A0 (en)	2000-09-30
SK14102000A3 (sk)	2001-03-12
CN1125639C (zh)	2003-10-29
NO20004740D0 (no)	2000-09-22
JP2002507569A (ja)	2002-03-12

Publication	Publication Date	Title
AP2000001874A0 (en)	2000-09-30	Cellecoxib compositions
GB9917982D0 (en)	1999-09-29	Compositions
GB9811377D0 (en)	1998-07-22	Compositions
GB9924268D0 (en)	1999-12-15	Compositions
GB9828861D0 (en)	1999-02-17	Compositions
GB9904049D0 (en)	1999-04-14	Rapidly-soluble compositions
IL139733A0 (en)	2002-02-10	Novel compositions
IL138478A0 (en)	2001-10-31	Paroxetine compositions
GB9805782D0 (en)	1998-05-13	Compositions
GB2339693B (en)	2003-07-23	Anti-mollusc compositions
GB9827291D0 (en)	1999-02-03	Compositions
GB9903924D0 (en)	1999-04-14	Cosmectic compositions
GB9806810D0 (en)	1998-05-27	Compositions
GB0016470D0 (en)	2000-08-23	Compositions
GB9812818D0 (en)	1998-08-12	Dentfrice compositions
GB9903310D0 (en)	1999-04-07	Composition
GB2336535B (en)	2003-07-09	Compositions
GB9809347D0 (en)	1998-07-01	Compositions
GB9816050D0 (en)	1998-09-23	Compositions
GB9827690D0 (en)	1999-02-10	Compositions
GB9818278D0 (en)	1998-10-14	Compositions
AU2003200534A1 (en)	2003-06-05	Paroxetine compositions
HK1033810A (en)	2001-09-28	Paroxetine compositions
GB9817459D0 (en)	1998-10-07	Compositions
GB9808595D0 (en)	1998-06-24	Compositions